This is how the AI article summary could look. Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Cardiac biomarkers – and how to interpret them
Cardiac biomarkers are specific proteins and enzymes released into the bloodstream when the heart muscle is stressed or damaged. In modern medicine, these markers—combined with clinical symptoms, ECG readings, and imaging—are the “gold standard” for diagnosing Acute Coronary Syndrome (ACS) and monitoring chronic heart conditions.
Below is a comprehensive guide to the primary cardiac biomarkers used in clinical practice today.
1. Cardiac Troponins (cTnI and cTnT)
Troponin is the most sensitive and specific indicator of heart muscle (myocardial) injury.
-
Function: Proteins that regulate heart muscle contraction.
-
High-Sensitivity Troponin (hs-cTn): Modern labs use high-sensitivity assays that detect trace amounts of damage much earlier than older tests. Learn more about hs-cTn thresholds from the AHA.
Interpretation Timeline:
-
Initial Rise: 3–6 hours post-injury.
-
Peak Levels: 12–24 hours.
-
Duration: Remains elevated for 7–14 days.
Clinical Significance:
-
Rising/Falling Pattern: A “delta” (change) in levels over 3–6 hours is more diagnostic of a heart attack than a single high value.
-
Non-Cardiac Elevations: Elevated troponin can also be caused by sepsis, pulmonary embolism, myocarditis, or kidney disease.
2. B-type Natriuretic Peptide (BNP) and NT-proBNP
These are the primary biomarkers for Heart Failure and volume overload.
Interpretation Tips:
-
High Values: Suggest heart failure or fluid retention.
-
Rule-Out Power: According to clinical guidelines from the NIH, a normal BNP is highly effective at ruling out heart failure in patients with shortness of breath.
3. Creatine Kinase-MB (CK-MB)
While largely replaced by Troponin, CK-MB remains useful in specific scenarios.
-
Best Use Case: Because it returns to normal quickly (48–72 hours), it is useful for detecting re-infarction (a second heart attack) shortly after the first.
-
Limitation: Less specific than troponin; skeletal muscle injury can cause false positives.
4. Myoglobin
-
Timeline: The earliest marker to rise (1–2 hours).
-
Interpretation: Highly non-specific. While a negative result helps “rule out” an early MI, it is rarely used in isolation today.
Summary Table: Cardiac Biomarker Comparison
| Biomarker |
Primary Use |
Detection Time |
Specificity |
| Troponin (T or I) |
Myocardial Infarction |
3–6 Hours |
High |
| BNP / NT-proBNP |
Heart Failure / Strain |
N/A (Stress-based) |
Moderate |
| CK-MB |
Re-infarction |
3–6 Hours |
Moderate |
| Myoglobin |
Early Rule-out |
1–2 Hours |
Low |
Key Interpretation Principles
-
Trends are King: Serial testing reveals the “kinetic curve” of the injury.
-
Clinical Correlation: Always interpret biomarkers alongside an ECG and patient history.
-
The “Non-ACS” Elevation: Consider if a rise is due to Type 2 Myocardial Infarction (oxygen supply/demand imbalance).